Laura A Vella Selected Research

Laura A Vella Research Topics

10	COVID-19 01/2022 - 01/2020
7	Neoplasms (Cancer) 03/2024 - 01/2006
3	Infections 01/2022 - 08/2020
3	Thrombotic Microangiopathies 12/2021 - 12/2020
2	Lymphoma (Lymphomas) 03/2024 - 11/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2021
2	Macrophage Activation Syndrome 12/2021 - 04/2021
2	Vascular System Injuries 12/2021 - 04/2021
2	COVID-19 related pediatric multisystem inflammatory disease 05/2021 - 08/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024
1	IgA Deficiency 01/2023
1	Human Influenza (Influenza) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Asthma (Bronchial Asthma) 11/2020
1	Leukemia 11/2020
1	Hypersensitivity (Allergy) 11/2020
1	Persistent Infection 11/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2009

5	VaccinesIBA 03/2024 - 08/2009
5	Immunoglobulin G (IgG)IBA 01/2023 - 08/2020
5	AntibodiesIBA 01/2021 - 08/2009
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2009
3	CyclinsIBA 09/2009 - 01/2006
3	Cyclin B1IBA 09/2009 - 01/2006
3	Neoplasm Antigens (Tumor Antigens)IBA 09/2009 - 01/2006
2	fostamatinibIBA 01/2022 - 05/2021
2	Inflammation MediatorsIBA 01/2022 - 05/2021
2	P-SelectinIBA 01/2022 - 05/2021
2	ProteomeIBA 12/2021 - 04/2021
1	mRNA VaccinesIBA 03/2024
1	Immunoglobulin A (IgA)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Ferritins (Ferritin)IBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2020
1	CytokinesIBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Small Cytoplasmic RNAIBA 11/2019
1	AntigensIBA 08/2009
1	DNA (Deoxyribonucleic Acid)IBA 08/2009